Ultimele actualizari :
22/12/2014
Stabilitatea si compatibilitatea medicamentelor
Bine ati venit pe site-ul Stabilis. Daca doriti sa primiti ultimele noutati, trimiteti-ne adresa mail.

Pentru intrebari sau comentarii, contactati stabilis@wanadoo.fr
Baze de date  
Bibiografie : 1721
Molecula (substanta activa) : 676
Clasa farmacologica : 40
Stabilitatea solutiilor : 4112
Stabilitatea in amestec : 934
Incompatibilitati : 2528
Denumirea comerciala : 1925
Noutati - Molecula (substanta activa)  
Diverse Aerosol Citric acid 11/12/2014
Diverse Soluţie orală Cilazapril 11/12/2014
Diverse Colir Infliximab 11/12/2014
Anxiolitic Injectabil Lormetazepam 01/12/2014
Antibiotic Injectabil Dalbavancin 30/11/2014
Diverse Injectabil Sodium oxybate 30/11/2014
Antibiotic Injectabil Tedizolid 30/11/2014
Diverse Injectabil Conivaptan 23/11/2014
Citostatic Injectabil Obinutuzumab 23/11/2014
Citostatic Injectabil Belinostat 23/11/2014
Diverse Injectabil Metaraminol 23/11/2014
Imunosupresor Injectabil Vedolizumab 07/09/2014
Antiinflamator Unguente Mometasone furoate 06/09/2014
Diverse Unguente Marigold tincture 06/09/2014
Diverse Unguente Arnica tincture 06/09/2014
Antidepresiv Soluţie orală Fluoxetine 06/09/2014
Anestezic local Picături pentru urechi Tetracaine 09/06/2014
Antibiotic Picături pentru urechi Clotrimazole 09/06/2014
Antihipertensiv Soluţie orală Valsartan 09/06/2014
Anticoagulant Injectabil Defibrotide 08/06/2014
Noutati - Bibiografie  
Data de intrare
3728 Visual compatibility of defibrotide with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 09/09/2014
3701 Defibrotide (Defitelio® - Summary of Product Characteristics) Gentium SPa 01/07/2014
3658 Omeprazole 40 mg Powder for Solution for Infusion - Summary of Product Characteristics. Sandoz 02/05/2014
3656 Teicoplanine (Targocid®) - Résumé des caractéristiques du produit Sanofi Aventis France 25/04/2014
3657 Rituximab (Mabthera®) - Résumé des caractéristiques du produit Roche 25/04/2014
3633 Bevacizumab (Avastin®) - Summary of Product Characteristics Roche 19/03/2014
3626 Tacrolimus (Prograf®) - Summary of Product Characteristics) Astellas Pharma 17/03/2014
3527 Amoxil vials for injection Glaxo Smith Kline 16/12/2013
3501 Ketalar® Summary of Product Characteristics Pfizer 08/12/2013
3503 Fentanyl solution for injection - Summary of product Characteristics Hamelm Pharmaceuticals 08/12/2013
3473 L'épirubicine concentrée à 8,33 mg/mL conditionnée en seringue pour chimioembolisation est stable 72 heures à +4°C à l'abri de la lumière. SFPO Congress, Mandelieu, France 09/11/2013
3459 Compatibility of intravenous fosaprepitant with intravenous 5-HT3 antagonists and corticosteroids. Cancer Chemother Pharmacol 31/10/2013
3448 Physicochemical stability study of a new Trimix formulation for treatment of erectile dysfunction. Ann Pharm Fr 22/10/2013
3446 Stabilité physicochimique de solutions diluées d'ipilimumab : résultats préliminaires à 1 mois. SFPO Congress, Mandelieu, France 21/10/2013
3447 Etude de la stabilité d’une solution de bortézomib à 2,5 mg/mL par chromatographie liquide à haute performance couplée à un détecteur à barrettes de diodes et à un détecteur évaporatif à diffusion de lumière. SFPO Congress, Mandelieu, France 21/10/2013
3443 Stability of Diluted Iron Polymaltose in PVC Infusion Bags. J Pharm Pract and Res 20/08/2013
3432 Istodax® (Romidepsin) Highlights of prescribing information Celgene Corporation 30/07/2013
3433 Stability of dexmedetomidine in polyvinyl chloride bags containing 0.9% sodium chloride injection. Am J Health-Syst Pharm 30/07/2013
3434 Compatibility and Stability of Morphine Sulphate and Naloxone Hydrochloride in 0.9% Sodium Chloride for Injection. Can J Hosp Pharm 30/07/2013
3435 Stability of Diluted Ketamine Packaged in Glass Vials. Can J Hosp Pharm 30/07/2013
3438 A stability-indicating, ion-pairing, reversed-phase liquid chromatography method for studies of daunorubicin degradation in i.v. infusion fluids. J Pharm Biomed Anal 30/07/2013
3428 Y-site compatibility of vancomycin and piperacillin/tazobactam at commonly utilized pediatric concentrations. Hosp Pharm 03/07/2013
3418 Chemical stability of bortezomib solutions in original manufacturer vial at room temperature and in syringe at 4°C. Int J Pharm Bio Sci 25/06/2013
3420 Stabilité physico-chimique d'un mélange intradermique de bléomycine-lidocaïne-adrénaline dilué en poche de NaCl 0,9%. Hopipharm Congress, Lyon France May 2013 25/06/2013
3422 Stability of Diluted Adenosine Solutions in Polyolefin Infusion Bags. Hosp Pharm 25/06/2013
3417 Aliquotierte Levosimendanlösungen - stabil ? ADKA Congress, Dresden, Germany 28/05/2013
3415 Stability-Indicating HPLC Assay and Stability Study Over Two Years of Morphine Hydrochloride Diluted Solutions in Polypropylene Syringes Pharmaceut Anal Acta 17/05/2013
3413 Oxaliplatin degradation in the presence of chloride: Identification and cytotoxicity of the monochloro monooxalato complex. Pharm Res 14/05/2013
3409 Stability of extemporaneously compounded diltiazem hydrochloride infusions stored in polyolefin bags Am J Health-Syst Pharm 13/05/2013
3408 Evaluation visuelle de la compatibilité physique de la naloxone avec d’autres médicaments intraveineux usuels. Pharmactuel 18/04/2013

Site créé par Cyril Labbé - Temps de calcul serveur : 86 millisecondes